EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,002 Cr | ₹1,859 Cr | ₹1,648 Cr | ₹1,309 Cr | ₹1,475 Cr |
What is the latest Sundry Debtors ratio of EMCURE PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,002 Cr |
| Mar2024 | ₹1,859 Cr |
| Mar2023 | ₹1,648 Cr |
| Mar2022 | ₹1,309 Cr |
| Mar2021 | ₹1,475 Cr |
How is Sundry Debtors of EMCURE PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,002 Cr | 7.72 | |
| Mar2024 | ₹1,859 Cr | 12.77 | |
| Mar2023 | ₹1,648 Cr | 25.97 | |
| Mar2022 | ₹1,309 Cr | -11.31 | |
| Mar2021 | ₹1,475 Cr | - | |
Compare Sundry Debtors of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,667.4 Cr | -2.8% | -0.6% | 30.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.8% |
-0.6% |
30.3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses